S-OA-G Oral Abstracts - Session G - Allogeneic Transplants

Track: BMT Tandem "Scientific" Meeting
Friday, February 15, 2013: 10:30 AM-12:00 PM
Ballroom A-D (Salt Palace Convention Center)
Chairs:
Claudio G. Brunstein, MD, PhD and Vikas Gupta, MD, FRCP, FRCPath
Summary:

Abstracts: #2829, 2188, 2256, 2429, 2339, 2372

14
Changes in HLA Antigens Is Not a Major Mechanism of Acute Myeloid Leukemia Relapse After Matched Allogeneic Stem Cell Transplantation
Amir Hamdi, MD, The University of Texas MD Anderson Cancer Center; Marcelo A. Fernandez Vina, PhD, The University of Texas MD Anderson Cancer Center; Fleur Aung, MD, The University of Texas MD Anderson Cancer Center; LM Poon, MD, The University of Texas MD Anderson Cancer Center; Steven Kornblau, The University of Texas MD Anderson Cancer Center; Kai Cao, MS, MD D(ABHI), The University of Texas MD Anderson Cancer Center; Richard E. Champlin, MD, The University of Texas MD Anderson Cancer Center; Stefan O. Ciurea, MD, The University of Texas MD Anderson Cancer Center

22
Platelet Engraftment Failure Leads to Poor Overall Survival Even after Neutrophil Engraftment without Relapse
Fumihiko Kimura, MD, PhD, National Defense Medical College; Shinichi Kobayashi, MD, PhD, National Defense Medical College; Kazuteru Ohashi, MD, PhD, Tokyo Metropolitan Cancer and Infectious diseases Center; Shuichi Taniguchi, MD, PhD, Toranomon Hospital; Takehiko Mori, MD, PhD, Keio University School of Medicine; Masami Inoue, MD, PhD, Medical Center and Research Institute for Maternal and Child Health; Hisashi Sakamaki, MD, PhD, Tokyo Metropolitan Cancer and Infectious diseases Center; Hiromasa Yabe, MD, PhD, Tokai University School of Medicine; Yasuo Morishima, MD, PhD, Aichi Cancer Center Research Institute; Koji Kato, MD, PhD, Japanese Red Cross Nagoya First Hospital; Ritsuro Suzuki, MD, PhD, Nagoya University; Takahiro Fukuda, MD, PhD, National Cancer Center Hospital

25
Significantly Higher Rates of Donor Attrition in Minority Ethnic, Female and Older Donors: A Review of 7542 Confirmatory Typing Requests at Anthony Nolan
Robert Lown, Anthony Nolan; Ailsa Ogilvie, Anthony Nolan; Alejandro Madrigal, MD PhD FRCP FRCPath DSc, Anthony Nolan; Bronwen Shaw, Anthony Nolan

27
The Schedule and Dose of Alemtuzumab Determine the Incidence of Mixed Chimerism in Pediatric Patients Undergoing Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation
Rebecca A Marsh, MD, Cincinnati Children's Hospital Medical Center; Mi-Ok Kim, Cincinnati Children's Hospital Medical Center; Chunyan Liu, Cincinnati Children's Hospital Medical Center; Denise Bellman, Cincinnati Children's Hospital Medical Center; Laura Hart, Cincinnati Children's Hospital Medical Center; Michael B. Jordan, MD, Cincinnati Children's Hospital Med Ctr; Jack Bleesing, MD, PhD, Cincinnati Children's Hospital Medical Center; Parinda A. Mehta, MD, Cincinnati Children's Hospital Medical Center; Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center; Kasiani Myers, MD, Cincinnati Children's Hospital Medical Center; Ashish Kumar, MD, PhD, Cincinnati Children's Hospital Medical Center; Michael Grimley, MD, Cincinnati Children's Hospital Medical Center; Stella M. Davies, MBBS, PhD, Cincinnati Children's Hospital Medical Center; Lisa Filipovich, MD, Cincinnati Children's Hospital Medical Center

28
Pretargeted Radioimmunotherapy Using an Anti-CD45 Antibody-Streptavidin Conjugate and Radiolabeled DOTA-Biotin in Patients with High-Risk Acute Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation
Raya Mawad, MD, Fred Hutchinson Cancer Research Center; Ted Gooley, PhD, Fred Hutchinson Cancer Research Center; Joseph G. Rajendran, MD, University of Washington; Darrell R. Fisher, PhD, Pacific Northwest National Laboratory; Andrew Shields, MD, University of Washington; Johnnie J. Orozco, MD, PhD, University of Washington; Donald K. Hamlin, BS, University of Washington; D. Scott Wilbur, PhD, University of Washington; Mark D. Hylarides, PhD, Fred Hutchinson Cancer Research Center; Ajay K. Gopal, MD, Fred Hutchinson Cancer Research Center; Damian J Green, MD, Fred Hutchinson Cancer Research Center; David G. Maloney, MD, PhD, Fred Hutchinson Cancer Research Center; Brenda M. Sandmaier, MD, Fred Hutchinson Cancer Research Center; Rainer F. Storb, MD, Fred Hutchinson Cancer Research Center; Frederick R. Appelbaum, MD, Fred Hutchinson Cancer Research Center; Oliver W. Press, MD, PhD, Fred Hutchinson Cancer Research Center; John M. Pagel, MD, PhD, Fred Hutchinson Cancer Research Center

34
Outcomes After Double Cord Blood Transplantation Compared to Single Cord Blood Transplantation in Adults with Acute Leukemia Given a Reduced Intensity Conditioning Regimen
Vanderson Rocha, MD, PhD, Eurocord; Myriam Labopin, MD, Service d’Hématologie et Thérapie Cellulaire, AP-HP, UPMC Université Paris 6, UMR-S 938, CEREST-TC EBMT, Hôpital Saint Antoine; Annalisa Ruggeri, MD, Eurocord International Registry, Paris, France; Didier Blaise, MD, Institut Paoli Calmettes; Bernard Rio, MD, Hotel Dieu; Jan Cornelissen, MD, PhD, Dr. Daniel Den Hoed Cancer Center; Noel Milpied, BMT unit; Luciana Tucunduva, MD, Eurocord International Registry, Paris, France; Arnon Nagler, MD, Chaim Sheba Medical Center; Mohamad Mohty, CHU de Nantes - Hotel-Dieu; Eliane Gluckman, MD RFCP, Eurocord

See more of: BMT Tandem "Scientific" Meeting
<< Previous Session | Next Session >>